On Jan. 25, 2019, the longest partial government shutdown in history came to an end, when President Trump announced he and bipartisan congressional leaders had reached an agreement to temporarily fund and re-open the federal government through mid-February while they continue working out a larger immigration and border security compromise.
As the federal government shutdown stretches past one month, CLSA continues to monitor the situation, including the operations of agencies critical for life sciences innovation.
With the opening of the 116th Congress, California’s congressional delegation in the House of Representatives continues to rank amongst the most influential, with numerous members serving in positions of leadership and on committees with jurisdiction over issues and policies critical to the continued advancement of our state’s and the nation’s life sciences sector. Notably, California’s 46 Democratic members comprise 20% of all House Democrats – the current majority party.
On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes Congressman Gil Cisneros (D–Yorba Linda). We look forward to working with Rep. Cisneros and his team to advance policies that improve patient health and bring positive change for California patients and their families.
In October, the Administration unveiled a plan with the intention to lower Medicare Part B costs and medication list prices over 5 years. Specifically, the proposal will set certain Part B drug prices based on an “International Pricing Index” (IPI).
The House of Representatives is expected to vote this month on a tax extenders package that, among other things, includes a 5-year suspension of the medical device excise tax.
By Jenny Nieto Nov. 16, 2018 On Nov. 16, CLSA was honored to convene a Meet & Greet with Representative-elect Mike Levin (D-San Juan Capistrano/San Diego) at our Washington, DC office. As you may know, attorney Mike Levin was elected Nov. 6 to serve as the new U.S. Representative for California’s 49th Congressional District. He … Continue reading CLSA Hosts Meet & Greet with Congressman-elect Mike Levin (CA-49)
CLSA’s federal government relations team is pleased to provide you with this update on the 2018 Midterm Elections, including the likely makeup of our incoming California delegation for the 116th Congress, and additional details on several key California congressional races you may be interested in.
Addressing drug pricing and improving healthcare access and affordability remains a salient topic on Capitol Hill, in the Trump Administration, with industry and the public. Over the summer, the Administration released its American Patients First blueprint, and over the past several weeks, the Administration has announced draft or final proposals intended to lower drug prices and increase access to affordable prescription drugs.
Both the House and Senate have adjourned until after the midterm elections. While the outcome of the elections will determine whether the Democrats win a majority in either the House or the Senate (or both), or if the Republicans maintain control of one or both chambers in the 116th Congress, both the House and Senate will return to Washington, D.C. in late November and early December (approximately 16-20 legislative days) to finish legislative work prior to the end of the year and the 115th Congress.